How many insider declarations has Cassidy Bernard J filed?

Cassidy Bernard J has filed 3 public insider declarations with SEC (Form 4).

What is Cassidy Bernard J's role?

Cassidy Bernard J's reported role is not specified by the regulator across the filings.

Which companies does Cassidy Bernard J report trades for?

Cassidy Bernard J reports trades for 2 companies, including Sana Biotechnology, Inc..

← Executives ★ Sign in to follow

CB

Cassidy Bernard J

OFFICER

·SEC (Form 4)

Sana Biotechnology, Inc.Juno Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the full record of transactions filed by Cassidy Bernard J. Officer active across 2 companies, notably Sana Biotechnology, Inc.. Aggregated, 3 reports have been recorded. Breakdown: 0 buy · 2 sells. History available since 7 March 2025. The latest transaction was disclosed on 7 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to Cassidy Bernard J

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Sana Biotechnology, Inc. (US)Juno Therapeutics, Inc. (US)

申报3 总计

◇

Cassidy Bernard J

EVP & General Counsel高管2025年3月7日Sana Biotechnology, Inc.

0SEC ↗

11,041 股0Common StockSEC:0001562180-25-002273:0

▼

Cassidy Bernard J

General Counsel and Secretary高管2016年1月19日Juno Therapeutics, Inc.

0SEC ↗

2,400 股Common StockSEC:0000899243-16-011990:0

▼

Cassidy Bernard J

General Counsel and Secretary高管2016年1月19日Juno Therapeutics, Inc.

0SEC ↗

800 股Common StockSEC:0000899243-16-011990:1

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

CB

Cassidy Bernard J

OFFICER

·SEC (Form 4)

Sana Biotechnology, Inc.Juno Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the full record of transactions filed by Cassidy Bernard J. Officer active across 2 companies, notably Sana Biotechnology, Inc.. Aggregated, 3 reports have been recorded. Breakdown: 0 buy · 2 sells. History available since 7 March 2025. The latest transaction was disclosed on 7 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.